An interventional study of Music Therapy and Pink Noise in Psoriasis (PsO) and Anxiety, sponsored by University of California, San Francisco. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-23.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Supportive care
Among 18 studies in Psoriasis by University of California, San Francisco — 6 open to participants now, 6 under way, none of them phase 3. Psoriasis · University of California, San Francisco.
Among the 18 studies in Psoriasis by University of California, San Francisco, this one has the largest planned enrollment of the 17 interventional ones that give a count, is one of 3 that started in 2026, is one of 5 with no phase, and was the 17th registered.
2,030 studies on the registry are indexed under Psoriasis; 277 are open to participants now.
Browse Psoriasis studies →6 of the 18 studies in Psoriasis by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:
University of California, San Francisco · Sites in United States
Ages 18+ · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 18–75
University of California, San Francisco · Sites in United States
Ages 18+ · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 18–75
University of California, San Francisco · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 174 Psoriasis studies recruiting now, 91 (52%) set no upper age limit and 67 (39%) stop at 75 or younger; 25 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 75 across 1,567 interventional studies indexed under Psoriasis.
Median enrollment 18 across the 17 interventional studies, 24 across the 1 observational. Of the 12 that completed or were terminated, 9 (75%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of California, San Francisco is the lead sponsor of 2,170 studies on the registry; 370 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 203 (76%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Psoriasis by University of California, San Francisco, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants listen to the iso-principle music with added auditory beat stimulation playlist for 23-30 minutes.
Behavioral: Music Therapy
Participants listen to the pink noise playlist for 23-30 minutes.
Behavioral: Pink Noise
Participants listen to the iso-principle music with added auditory beat stimulation playlist for 23-30 minutes.
Also known as: Music therapy and auditory beat stimulation (ABS), Music, Complementary Therapy, Complementary Therapies, Acoustic Stimulation
Participants listen to the pink noise playlist for 23-30 minutes.
Anxiety: State Trait Inventory for Cognitive and Somatic Anxiety (STICSA)
The STICSA has good reliability and validity as a measure of state and trait cognitive and somatic anxiety. In this study, the post-intervention anxiety score is subtracted from the pre-intervention anxiety score, giving a measure of anxiety reduction. Greater anxiety reduction scores would indicate a better anxiety outcome.
Time frame: From the pre-intervention survey to the post-intervention survey, approximately 30 minutes.
Mood: Positive and Negative Affect Scale (PANAS)
The PANAS has demonstrated good reliability and validity, and has been widely used in numerous studies to assess mood. In this study, the post-intervention PANAS scores are subtracted from the pre-intervention PANAS scores, giving a measure of positive and negative mood changes. The scale generates two scores: 1) Positive affect (higher score indicates better mood outcome) and 2) Negative affect (higher score indicates worse mood outcome).
Time frame: From the pre-intervention survey to the post-intervention survey, approximately 30 minutes.
Itch: Itch Numeric Rating Score (INRS)
The INRS has good reliability and validity as a measure of 24-hour itch severity, though validity testing over more acute intervals remains limited. In this study, the post-intervention itch score is subtracted from the pre-intervention itch score, giving a measure of itch reduction. Greater itch reduction scores may indicate a better itch outcome.
Time frame: From the pre-intervention survey to the post-intervention survey, approximately 30 minutes.
Plan to share: No
Started Feb 2026 (actual). Primary completion is estimated for Dec 2027, 22 months after the start.
Of 115 non-industry interventional studies with no phase under Psoriasis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 22 months is close to that.
Counting every sponsor, half of 134 studies reached it within 19 months; a quarter within 8 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco →